
Britzilam 100mg Tablet SR
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Brivaracetam (100mg)
Overview Britzilam 100mg Tablet SR
Epileptic seizures are managed with the anticonvulsant medication, Britzilam 100mg Sustained-Release Tablets. This medication, administered alone or in conjunction with other treatments, controls seizures by suppressing abnormal brain electrical activity, providing ongoing seizure prevention with consistent use. Taken regularly, with or without food, at the same time daily optimizes effectiveness. Dosage and frequency are determined individually by your physician to achieve optimal seizure control, potentially increasing gradually. Long-term use is typically recommended; continue as directed, even if feeling well, as discontinuation or missed doses risk increased seizure activity. Never cease treatment without physician consultation, as abrupt cessation may worsen seizures. Common side effects, often lessening after initial weeks, include dizziness, headache, nausea, vomiting, and behavioral changes such as aggression, irritability, or agitation. While many side effects resolve without intervention, some are serious. Suicidal ideation has been reported in a small number of patients; contact your doctor immediately if mood deteriorates. Prior to commencing treatment, inform your doctor about pre-existing liver or kidney conditions, depression, suicidal thoughts, pregnancy, or pregnancy plans. Breastfeeding mothers should also seek medical advice before use.
Primary Ingredients of Britzilam 100mg Tablet SR
There is no text provided to rephrase.
Uses of Britzilam 100mg Tablet SR
Convulsive disorders
Major Benefits of Britzilam 100mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Britzilam 100mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Britzilam 100mg Tablet SR:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Britzilam 100mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Britzilam 100mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Britzilam 100mg Tablet SR works:
Extended-release Britzilam 100mg tablets are used to control epileptic seizures. Their mechanism involves binding to SV2A receptors located on neuronal membranes. This binding action inhibits excessive neuronal firing, thus preventing the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Britzilam 100mg Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Britzilam 100mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Britzilam 100mg sustained-release tablets with breastfeeding are absent. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Britzilam 100mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Britzilam 100mg SR tablets are considered safe, and no dosage modification is advised. However, their use is not recommended in end-stage renal disease because of insufficient clinical study data.
LiverCAUTION
Patients with hepatic impairment should use Britzilam 100mg sustained-release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Britzilam 100mg Tablet SR :
NA
Facts to Know About Britzilam 100mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |
